Characteristics

All

FOXC2

p-value

(N = 50)

Low

(N = 20)

High

(N = 30)

No.

(%)

No.

(40%)

No.

(60%)

Age (years)

Mean ± SD

56.23 ± 10.99

49.91

±8.72

60.16

±10.50

0.002

Median (Range)

56 (39 - 87)

45

(39 - 67)

60

(40 - 87)

≤55 years

18

36%

14

(65.2%)

4

(21.6%)

<0.001‡

>55 years

32

64%

6

(34.8%)

26

(78.4%)

Pathological type

IDC

39

78%

14

(49%)

25

(51%)

0.448‡

Other

11

22%

6

(36.4%)

5

(63.6%)

Grade

Grade I

7

14%

5

(30.4%)

2

(8.1%)

0.03§

Grade II

13

26%

9

(39.1%)

4

(16.2%)

Grade III

30

60%

6

(30.4%)

24

(75.7%)

ER

Negative

20

40%

2

(4.2%)

18

(95.8%)

0.009‡

Positive

30

60%

18

(75%)

12

(25%)

PR

Negative

22

45%

2

(4.2%)

20

(80%)

0.008‡

Positive

28

55%

18

(75%)

10

(20%)

HER2/neu

Negative

30

40%

18

(77.1%)

12

(22.9%)

0.02‡

Positive

20

60%

2

(4%)

18

(96%)

Ki-67

Negative

20

40%

15

(87%)

5

(13%)

<0.001‡

Positive

30

60%

5

(21.6%)

25

(78.4%)

Molecular type

Luminal A

25

41.7%

25

(100%)

0

(0%)

<0.001‡

Luminal B

10

16.7%

1

(10%)

9

(90%)

HER2 amplified

15

25%

0

(0%)

15

(100%)

Triple-ve

10

16.7%

2

(20%)

8

(80%)

T

T1

8

16%

8

(39.1%)

0

(0%)

0.002§

T2

10

20%

6

(26.1%)

4

(13.5%)

T3

22

44%

5

(34.8%)

17

(37.8%0

T4

10

20%

1

(0%)

9

(37.8%)

N